Bleakley Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bleakley Financial Group's LLY Position: Q2 2026 in Review
Bleakley Financial Group increased its Eli Lilly (LLY) stake by 17% in Q2 2026, buying an estimated $6.69M and bringing the position to 45,004 shares worth $54M. The position accounts for 0.69% of the portfolio, ranked #35.
Bleakley Financial Group first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bleakley Financial Group held 45,004 shares of Eli Lilly worth $54M as of Q2 2026.
- Bleakley Financial Group bought 6,552 Eli Lilly shares in Q2 2026, an estimated $6.69M.
- Eli Lilly made up 0.69% of Bleakley Financial Group's portfolio in Q2 2026, its #35 holding.
- Bleakley Financial Group first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
- 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.